While there are currently limited studies that demonstrate the relationship between GNRHR and drugs on the side effect of dermatitis, Han et al. (2023) recently administered the GnRH antagonist Relugolix which revealed lichenoid dermatitis with eosinophils 9 weeks post-treatment. Here, GNRH1 is linked to dermatitis.